Valeritas gets C Mark OK for disposable insulin device; Carticept gets FDA clearance for Navigator;

> New Jersey-based Valeritas has received European C Mark approval for its V-Go disposable insulin delivery device. Release

> Carticept Medical, based in Georgia, has received FDA clearance to market its Navigator computer controlled drug delivery system. Article

> Micell Technologies has finished enrolling patients in its DESSOLVE II CE Mark clinical study of the MiStent Drug-Eluting Coronary Stent System. The Durham, NC company has enrolled 183 patients across 26 centers throughout Europe and New Zealand. Release

> Drug delivery patent of the week: Pharmaceutical compositions and methods for delivering nucleic acids into cells. Patent